Baxter International Inc BAX
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1961-05-15 |
| Shares Out. | 516,470,000 |
| Website | baxter.com/ ↗ |
| Phone | 12249482000 |
| Employees | 37,500 |
| Revenue | $2.70B |
| Gross Profit | $891.0M |
| Net Income | -$15.0M |
| Free Cash Flow | $723.0M |
| Total Assets | $19.85B |
| Total Liabilities | $13.83B |
| Equity | $6.02B |
About Baxter International Inc
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Baxter International Inc is a publicly traded company under the ticker symbol BAX on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
24 analysts (2026-07-01)
